New findings add to questions about existence of gouty nephropathyJanuary 13, 2021NephrologyRheumatology
FDA expands belimumab indication to adults with lupus nephritisDecember 18, 2020NephrologyRheumatology
ADA 2021 standards address financial hardship in diabetesDecember 15, 2020DiabetesCardiologyNephrology
New guidelines address diabetes management in kidney diseaseNovember 13, 2020DiabetesEndocrinologyNephrology
New eGFR equation ‘less biased’ by age, kidney function; some disagreeNovember 10, 2020NephrologyEndocrinologyMixed TopicsGastroenterology
Novel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesNephrologyCardiologyMixed Topics
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesEndocrinologyCardiologyNephrology
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor useSeptember 25, 2020DiabetesMixed TopicsNephrologyEndocrinologyCardiology
Deaths sky high in hospitalized COVID patients with kidney injurySeptember 9, 2020COVID-19 UpdatesNephrology
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetesAugust 31, 2020DiabetesCardiologyNephrologyEndocrinology
Real-world data show SGLT2 inhibitors for diabetes triple DKA riskJuly 29, 2020DiabetesEndocrinologyNephrologyCardiology
Terlipressin squeaks by FDA review for hepatorenal syndrome 1July 17, 2020GastroenterologyNephrologyRare Diseases
